PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma
Main Authors: | Qin Xie, Shuaishuai Chi, Yanfen Fang, Yiming Sun, Linghua Meng, Jian Ding, Yi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-021-00522-6 |
Similar Items
-
ANGIOGENESIS INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
by: Massimiliano Berretta, et al.
Published: (2016-11-01) -
The Akt inhibitor ISC-4 synergizes with cetuximab in 5-FU-resistant colon cancer.
by: Joshua E Allen, et al.
Published: (2013-01-01) -
Mitochondrial Complex I Inhibitors and Forced Oxidative Phosphorylation Synergize in Inducing Cancer Cell Death
by: Roberta Palorini, et al.
Published: (2013-01-01) -
Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
by: Joshua E. Allen, et al.
Published: (2013-01-01) -
Correction: The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer.
by: Joshua E. Allen, et al.
Published: (2013-01-01)